Table: SymBio Pharmaceuticals - 9-MTH group results

SymBio Pharmaceuticals

30/10/2025 06:32

Oct 30 (Reuters)- 
             SymBio Pharmaceuticals Limited 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to  
                Sep 30, 2025        Sep 30, 2024      Dec 31, 2025  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            970 mln              1.90              1.40      
                 (-48.9 pct)         (-57.1 pct)       (-42.9 pct)  
  Operating       loss 3.34           loss 2.79         loss 4.26   
  Recurring       loss 3.54           loss 2.76         loss 4.47   
  Net             loss 3.57           loss 2.85         loss 4.59   
  EPS          loss 73.46 yen      loss 63.43 yen    loss 95.95 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - SymBio Pharmaceuticals Limited. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4582.T